Karnavati Financ (538928)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Latest quarter shows net profit of ₹1 Cr on sales of ₹2 Cr, a possible inflection from earlier negative returns.
• Reported sales growth of 456% and profit growth of 1,000% indicate expanding activity, albeit from a very small base.
• Piotroski F-Score of 6/9 offers some mild evidence of improving financial health.
• Stock trading at its 52-week high of ₹2.30 suggests recent market recognition of the turnaround attempt.

Concerns

• ROE of -8.78% and ROCE of -2.09% mean current operations are destroying shareholder value.
• P/B of 2.09 against book value of ₹1.10 leaves no margin of safety for a low-return, sub-₹25 Cr NBFC.
• P/E of 0.00 and tiny absolute earnings make the high growth percentages misleading.
• Zero dividend, no promoter holding data, and no debt/equity disclosure impair a value investor's ability to judge the business.

AI Analysis

Let me be plain: at ₹2.30, Karnavati Financ is a tiny ₹23-crore NBFC, and the numbers do not support paying 2.09 times book value of ₹1.10. A P/E of 0.00 is not a sign of cheapness; it tells me trailing earnings are essentially absent. The latest quarter shows sales of ₹2 crore and net profit of ₹1 crore, and the reported 456% sales growth and 1,000% profit growth sound exciting only until you remember the base is minuscule. One good quarter does not make a compounding machine. My Graham framework starts with return on capital. Here ROE is -8.78% and ROCE is -2.09%. That means the business is currently destroying value on the equity shareholders have put in. If I buy at 2 times book, I need the future returns to be far better; otherwise I am paying a large premium for a poor earner. No dividend and no debt/equity or promoter data leave me blind on capital structure and insider alignment. The Piotroski score of 6/9 is mildly encouraging, but it is not enough to overcome the lack of a moat. An NBFC needs low-cost funding, disciplined underwriting and trust; I see no evidence of a durable competitive advantage here. I am not saying the company cannot improve. It may be turning around: the latest quarter is profitable, and the stock sits at its 52-week high of ₹2.30. But value investors do not pay up for hope. I need to see sustained earnings, positive ROE over several quarters, and much better disclosure before this becomes an investable idea. Until then, the math says pass.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer